Nova .(US:NVMI) Seeking Alpha·2025-11-26 00:33Core Insights - Nova Eye is focusing on the clinical use of the iTrack Advance and is sharing insights from the field with the participation of Dr. Khaimi, a leading glaucoma surgeon [1][2] Group 1: Company Overview - Nova Eye's Medical CEO, Thomas Spurling, introduced Dr. Khaimi, highlighting his expertise in canal-based surgery and his significant contributions to the field [1][2] - Dr. Khaimi is recognized as one of the most experienced canal-based surgeons globally and has played a pivotal role in the development and rollout of the canaloplasty technique [2][3] Group 2: Product Development - The iTrack Advance product was developed in collaboration with Dr. Khaimi, focusing on ergonomics and functionality, with work dating back to 2022 [3] - Dr. Khaimi's extensive experience at the Dean McGee Eye Institute has contributed to the training of future glaucoma specialists and the advancement of glaucoma services [3]